News from Sirnaomics, Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Dec 06, 2017, 08:58 ET Sirnaomics' Leading siRNA Therapeutic Candidate, STP705, Granted Orphan Designation for Treatment of Cholangiocarcinoma

Sirnaomics, Inc. (www.sirnaomics.com), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that...


Oct 06, 2017, 08:28 ET Sirnaomics Publishes Results Showing Dual Targeting of TGF-β1 and COX-2 Reduces Human Skin Hypertrophic Scar through Activation of Fibroblast Apoptosis

Sirnaomics, Inc. (www.sirnaomics.com), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, has published results...


Aug 01, 2017, 09:08 ET Sirnaomics Leading siRNA Therapeutic Candidate, STP705, Granted Orphan Designation for the Treatment of Primary Sclerosing Cholangitis (PSC)

Sirnaomics, Inc. (www.sirnaomics.com), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that...


Jun 15, 2017, 08:58 ET Sirnaomics Advances Leading siRNA Therapeutic Candidate, STP705, for Treatment of Liver Fibrosis

Sirnaomics, Inc. (www.sirnaomics.com), a leading biopharmaceutical company in discovery and development of RNAi therapeutics,...


May 01, 2017, 11:22 ET Sirnaomics Received IND Approval from CFDA for Its Leading siRNA Therapeutic Candidate, STP705, for Treatment of Hypertrophic Scar

Sirnaomics, Inc. (www.sirnaomics.com), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announces today that...


Feb 06, 2017, 09:00 ET Sirnaomics Initiates a Clinical Phase IIa Study of Its Leading siRNA Therapeutic Candidate, STP705, for Treatment of Hypertrophic Scar

Sirnaomics, Inc. (www.sirnaomics.com), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announces today that...


Nov 07, 2016, 08:58 ET Sirnaomics Received Green Light from US FDA for a Clinical Phase IIa Study of Its Leading siRNA Therapeutic Candidate, STP705, for Treatment of Hypertrophic Scar

Sirnaomics, Inc. (www.sirnaomics.com), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announces today that...


May 04, 2016, 08:30 ET Sirnaomics Raises $10 Million and Forges a Path to Clinical Development of Its Anti-fibrosis RNAi Therapeutics

 Sirnaomics, Inc. (www.sirnaomics.com), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, has closed...


Jan 05, 2015, 03:58 ET Sirnaomics and Partner Submit IND to CFDA for Its First Anti-fibrosis siRNA Therapeutic

 Sirnaomics, Inc. (www.sirnaomics.com) and its affiliate Suzhou Sirnaomics Pharmaceutics, Co. Ltd., (www.suzhou.sirnaomics.com), together with...


Dec 19, 2012, 10:00 ET Sirnaomics Advances Its Novel siRNA Therapeutics Against HPV Infection and Cervical Cancer

 Sirnaomics, Inc. (www.sirnaomics.com) announced today that the company has made a major breakthrough in its novel small interfering RNA...


Jun 25, 2012, 09:00 ET Sirnaomics Received NIH SBIR Grant for Developing Its Scarless Wound Healing siRNA Therapeutics

 Sirnaomics, Inc. (www.sirnaomics.com) announced today that the company has been awarded another NIH SBIR (Small Business Innovation Research)...


Jun 23, 2011, 09:18 ET Sirnaomics Seals a Second Partnership Deal with a Chinese Pharmaceutical Company for Developing siRNA Therapeutics

Sirnaomics, Inc. (www.sirnaomics.com) announced today that the company has signed a partnership agreement with Guangdong Zhongsheng Pharmaceutical...


Dec 02, 2010, 08:45 ET Sirnaomics Seals Partnership Deal for Development of RNAi Therapeutics in China

Sirnaomics, Inc. (www.sirnaomics.com) announced today that the company has cemented a partnership with a Chinese pharmaceutical company for...


Jun 29, 2010, 10:22 ET Sirnaomics Receives Two SBIR Grants from NIH for Developing siRNA Therapeutics to Treat Glioblastoma and Influenza Infection

Sirnaomics, Inc. (www.sirnaomics.com) announced today that the company has received two SBIR (Small Business Innovation Research) grants from...


Jan 13, 2010, 09:30 ET Sirnaomics Licenses Polypeptide Nanoparticle Technology for Its siRNA Therapeutic Product Development

Sirnaomics, Inc. (www.sirnaomics.com) announced today that the company has licensed a polypeptide nanoparticle technology invented by Professor A....


Jul 22, 2009, 14:00 ET Sirnaomics Receives SBIR Grant from NIH/NCI for Its Multi-Targeted Lung Cancer siRNA Therapeutics

Sirnaomics, Inc. (www.sirnaomics.com) announced today that the company has received an SBIR (small business innovation research) grant from...


Mar 12, 2008, 01:00 ET Sirnaomics and GRL Establish Partnership for the Development of Two Multi-Targeted RNAi Therapeutics Products

ROCKVILLE, Md., March 12 /PRNewswire/ -- General Research Laboratory, Inc. (GRL) and Sirnaomics, Inc. announced today that the companies are...


Dec 26, 2007, 00:00 ET Sirnaomics Received Multiple Government Fundings For Its Multi-Targeted siRNA Therapeutics Programs

ROCKVILLE, Md., Dec. 26 /PRNewswire/ -- Sirnaomics, Inc. announced today that the company has received funding from a variety of Government...